RESUMEN
Food allergy could affect up to 8% of children. Four cases of food anaphylaxis in hospitalized children are reported, pointing to the need of food allergenic safety procedures in hospital settings. The implementation of the operating procedure in hospital food production units (HFPU) of Nancy University Hospital is described. The dietetics Department developed on hypoallergenic diet and specific avoidance diets. Dieticians within HFPU managed the choice of starting materials, the circuit organization in order to avoid any risk of contamination during preparation and cooking of food, product traceability, and trained the staff of HFPU. Within the care units physicians, dieticians, nurses, hospital workers are involved in meal management. A diet monitoring sheet is integrated into the patient's nursing file and enables the dietician to validate the diet in the computer, the nurses to display the patient's diet on the schedule on the wall in their office. The hospital workers finally use a tray form indicating the patient's identity, his/her diet and the menu of the day. Such a procedure absolutely secures the whole circuit and specifies the responsibilities of each person, whilst ensuring effective cooperation between all partners. Since 1999, the implementation of this multi-step strategy has prevented from any further reaction in a department specialized for food allergies in children and in adults. As setting up food allergenic safety in hospitals in not addressed adequately in the European directives, it's judicious to draw attention of hospital catering managers and hospital canteen staff to this necessity.
Asunto(s)
Anafilaxia/etiología , Arachis/efectos adversos , Manejo de Caso , Aditivos Alimentarios/efectos adversos , Hipersensibilidad a los Alimentos , Conservantes de Alimentos/efectos adversos , Servicio de Alimentación en Hospital , Edema Laríngeo/etiología , Lupinus/efectos adversos , Pisum sativum/efectos adversos , Garantía de la Calidad de Atención de Salud/organización & administración , Sulfitos/efectos adversos , Ácido Acético , Anafilaxia/prevención & control , Cacao , Niño , Preescolar , Dieta , Dietética , Aditivos Alimentarios/administración & dosificación , Manipulación de Alimentos , Conservantes de Alimentos/administración & dosificación , Servicio de Alimentación en Hospital/organización & administración , Control de Formularios y Registros , Francia , Humanos , Edema Laríngeo/prevención & control , Masculino , Persona de Mediana Edad , Personal de Hospital/educación , Seguridad , Sulfitos/administración & dosificaciónRESUMEN
Infants (n = 35) with digestive symptom were investigated for diagnosis of cow's milk allergy (CMA). Milk atopy patch tests (APTs) were positive in 19 of 24 CMA versus 1 of 11 in non-CMA patients (P <.001). This sensitivity (79%) and specificity (91%) suggest that the APT could improve the detection of conditions related to CMA.
Asunto(s)
Estreñimiento/etiología , Diarrea/etiología , Insuficiencia de Crecimiento/etiología , Reflujo Gastroesofágico/etiología , Hipersensibilidad a la Leche/complicaciones , Hipersensibilidad a la Leche/diagnóstico , Pruebas del Parche/métodos , Estudios de Casos y Controles , Preescolar , Femenino , Humanos , Inmunoglobulina E/sangre , Lactante , Masculino , Hipersensibilidad a la Leche/sangre , Hipersensibilidad a la Leche/inmunología , Pruebas del Parche/normas , Sensibilidad y Especificidad , Pruebas CutáneasRESUMEN
Thirty-five children with atopic dermatitis were proven to be allergic to various foods by dietary elimination and challenge, radio-allergosorbent test (RAST) and human basophil degranulation test (HBDT). Oral sodium cromoglycate improved skin lesions in these patients and protected them from the effects of challenge with food allergens. This protective effect of oral sodium cromoglycate may be explained by the blocking of the immune response in the gut wall and of antigen entry.
Asunto(s)
Cromolin Sódico/uso terapéutico , Dermatitis Atópica/tratamiento farmacológico , Hipersensibilidad a los Alimentos/tratamiento farmacológico , Administración Oral , Adolescente , Basófilos/inmunología , Niño , Preescolar , Cromolin Sódico/efectos adversos , Gránulos Citoplasmáticos/inmunología , Humanos , Inmunoglobulina E/biosíntesis , Inmunoglobulina G/biosíntesis , Lactante , Prueba de RadioalergoadsorciónRESUMEN
Addition of a daily dose of androgen in the form of 0.15 mg/kg of Stanzolol, given without interruption, gave an average survival of more than 4 years in patients suffering from granulocyte series acute leukaemias after complete remission was obtained. The simplicity of this treatment is apparent only from the appearance of marked manifestations of androgen impregnation in women from the 8th month of treatment onwards. These results, superior to those obtained up to the present time in the survival of myeloid leukaemias (non-lymphoblastic) were also better in terms of the stability and X "quality" of the remission in comparison to those obtained in acute lymphoblastic leukaemias. Confirmation of these results by controlled clinical trial will open up interesting perspectives, along side immunotherapy which remains of unproven effectiveness in myeloid leukaemias. The effectiveness of androgen stimulation of haematopoiesis as a stabilising factor of complete remissions in acute leukaemias has, in addition, interesting implications with regard to the theory of the leukaemic process.